1. Home
  2. NEUP vs TKLF Comparison

NEUP vs TKLF Comparison

Compare NEUP & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • TKLF
  • Stock Information
  • Founded
  • NEUP 1996
  • TKLF 2006
  • Country
  • NEUP United States
  • TKLF Japan
  • Employees
  • NEUP N/A
  • TKLF N/A
  • Industry
  • NEUP
  • TKLF Other Specialty Stores
  • Sector
  • NEUP
  • TKLF Consumer Discretionary
  • Exchange
  • NEUP Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • NEUP 14.7M
  • TKLF 15.6M
  • IPO Year
  • NEUP N/A
  • TKLF 2022
  • Fundamental
  • Price
  • NEUP $4.55
  • TKLF $3.30
  • Analyst Decision
  • NEUP Strong Buy
  • TKLF
  • Analyst Count
  • NEUP 2
  • TKLF 0
  • Target Price
  • NEUP $28.00
  • TKLF N/A
  • AVG Volume (30 Days)
  • NEUP 4.7M
  • TKLF 171.8K
  • Earning Date
  • NEUP 11-21-2025
  • TKLF 12-17-2025
  • Dividend Yield
  • NEUP N/A
  • TKLF N/A
  • EPS Growth
  • NEUP N/A
  • TKLF N/A
  • EPS
  • NEUP N/A
  • TKLF 1.57
  • Revenue
  • NEUP $15,649,448.00
  • TKLF $210,119,238.00
  • Revenue This Year
  • NEUP N/A
  • TKLF N/A
  • Revenue Next Year
  • NEUP N/A
  • TKLF N/A
  • P/E Ratio
  • NEUP N/A
  • TKLF $2.10
  • Revenue Growth
  • NEUP N/A
  • TKLF 7.38
  • 52 Week Low
  • NEUP $2.90
  • TKLF $2.20
  • 52 Week High
  • NEUP $126.00
  • TKLF $5.10
  • Technical
  • Relative Strength Index (RSI)
  • NEUP 33.43
  • TKLF 43.02
  • Support Level
  • NEUP $4.53
  • TKLF $3.04
  • Resistance Level
  • NEUP $8.44
  • TKLF $3.48
  • Average True Range (ATR)
  • NEUP 1.19
  • TKLF 0.26
  • MACD
  • NEUP -1.03
  • TKLF -0.00
  • Stochastic Oscillator
  • NEUP 5.65
  • TKLF 43.77

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

Share on Social Networks: